Skip to content

Public FDA record

Z-1374-04: ProSpecT Giardia/Cryptosporidium Micorplate Assay. Catalog #: 2458496.

Recall record Z-1374-04 for Remel, Inc.. View source facts, labeled dates, and the original FDA record.

FDA identifier
Z-1374-04
Company in FDA record
Remel, Inc.
FDA classification date
Aug 17, 2004
First observed by MedTech Watch
Nov 16, 2026
Latest observed content change
Nov 20, 2026
Recall classification
Unknown — no matched enforcement classification

Reason stated in the source

The conjugate of the ProSpecT Giardia/Cryptosporidium Microplate Assay, Lot #926230, may have become contaminated during filling. The particulates in the contamination may cause the dropper tips to become plugged. Quality control testing indicated that the reagents were still performing as intended, including the conjugates.

Source facts

Action
A potential contamination was noted in the conjugate in the ProSpecT Giardia/Cryptosporidium Microplate Assay. The particulate in the conjugate may cause the dropper tip to become plugged.
Initiated
2002-11-21
Root cause
Other
Terminated
2004-09-15
Distribution
US only
Recall number
Z-1374-04
Recall status
Terminated
CDRH record ID
34335
FDA classified
2004-08-17
Recall event number
29679

Source facts and excerpts are reproduced for research. Dates retain their source meanings. “First observed” describes collection, not FDA publication or product launch.

Recall classification is supplied only when the recall number matches an enforcement record. Recall class and device class are different fields. Several recall records may belong to one recall event.

Useful context

Device classifications

FDA dataset:

Last successful check: Nov 22, 2026

Source classifications may change.

510(k) clearances

FDA dataset:

Last successful check: Nov 22, 2026

FDA publishes this dataset monthly.

Recall records

FDA dataset:

Last successful check: Nov 22, 2026

FDA publishes this dataset weekly.

Keep this research moving.

Follow ten competitors and ten product codes. Get matching changes in your dashboard and a weekly brief, for $49/month.

Start a 14-day free trial ↗